StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$17.53−1.03 (-5.55%)

Close on Nov 20, 2026Market cap $1.09BP/E –Yield –

GH Research free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

GH Research's free cash flow for the twelve months ending Jun 30, 2026 was -$51.84M. For fiscal 2025 it was -$43.67M. The highest annual figure on record is -$289.00K in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$43.67M–
FY2024Dec 31, 2024-$42.33M–
FY2023Dec 31, 2023-$33.44M–
FY2022Dec 31, 2022-$26.27M–
FY2021Dec 31, 2021-$15.39M–
FY2020Dec 31, 2020-$330.00K–
FY2019Dec 31, 2019-$289.00K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.04M–
Q1 FY2026Mar 31, 2026-$10.73M–
Q4 FY2025Dec 31, 2025-$12.35M–
Q3 FY2025Sep 30, 2025-$13.72M–
Q2 FY2025Jun 30, 2025-$9.03M–
Q1 FY2025Mar 31, 2025-$8.58M–
Q4 FY2024Dec 31, 2024-$10.47M–
Q3 FY2024Sep 30, 2024-$12.31M–
Q2 FY2024Jun 30, 2024-$9.94M–
Q1 FY2024Mar 31, 2024-$9.61M–
Q4 FY2023Dec 31, 2023-$8.11M–
Q3 FY2023Sep 30, 2023-$10.35M–
Q2 FY2023Jun 30, 2023-$8.07M–
Q1 FY2023Mar 31, 2023-$6.91M–
Q4 FY2022Dec 31, 2022-$6.89M–
Q3 FY2022Sep 30, 2022-$8.06M–

More GH Research figures

See a number that looks wrong?